(Q52009697)

19 April 2018

title

Treatment and Prevention of Depression. (English)

1 reference

19 April 2018

author name string

Steven D Hollon

series ordinal

1

1 reference

19 April 2018

Michael E Thase

series ordinal

2

1 reference

19 April 2018

John C Markowitz

series ordinal

3

1 reference

19 April 2018

publication date

1 November 2002

1 reference

19 April 2018

Psychological Science in the Public Interest

published in

1 reference

19 April 2018

volume

3

1 reference

19 April 2018

page(s)

39-77

1 reference

19 April 2018

issue

2

1 reference

19 April 2018

Antidepressant-induced mania and cycle acceleration: a controversy revisited

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Outcomes of time-limited psychotherapy in applied settings: Replicating the Second Sheffield Psychotherapy Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Drugs and Group Psychotherapy in Neurotic Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

The efficacy of brief dynamic psychotherapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A psychoeducational approach to the treatment of depression: A meta-analysis of lewinsohn's “coping with depression” course

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Specific psychotherapies for childhood and adolescent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Depression: perspectives from affective neuroscience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Empirically supported individual and group psychological treatments for adult mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Differential Symptom Reduction by Drugs and Psychotherapy in Acute Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A meta-analysis of the efficacy of cognitive therapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A molecular and cellular theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Systematic review and guide to selection of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

National Institute of Mental Health Treatment of Depression Collaborative Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Differential relapse following cognitive therapy and pharmacotherapy for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Natural history and preventative treatment of recurrent mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Interaction of Drug Therapy With Marital Therapy in Depressive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Tranylcypromine versus imipramine in anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Clinical importance of long-term antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Placebo-psychotherapy combinations: inappropriate representations of psychotherapy in drug-psychotherapy comparative trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Cognitive Therapy and Pharmacotherapy for Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Suicide prevention – a medical breakthrough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Short-Term Psychotherapy of Depressive Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Prevention of depressive symptoms in school children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Antidepressant medications and the relative risk of suicide attempt and suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Toward a clinical model of psychotherapy for depression, I: Systematic comparison of three psychotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program General Effectiveness Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Treatment of Depression by Drugs and Psychotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Maintenance therapy for chronic depression. A controlled clinical trial of desipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Psychotherapy of dysthymia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Treatment of depressive symptoms in human immunodeficiency virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Efficacy of interpersonal psychotherapy for depressed adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Out-patient compliance with antidepressant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Marital therapy: a viable treatment for depression and marital discord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

National trends in the outpatient treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Lithium-discontinuation-induced refractoriness: preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Continuation drug therapy for major depressive episodes: how long should it be maintained?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Validity of clinical trials of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A self-control model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

How are we doing in soft psychology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Bipolar disorder therapeutics: maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

The prevention of depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Response to maintenance therapy in bipolar illness. Effect of index episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Interpersonal psychotherapy for depressed antepartum women: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Cognitive therapy with inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Emergence of intense suicidal preoccupation during fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Venlafaxine and treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Bipolar depression: pharmacotherapy and related therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Treatment Effects on the Social Adjustment of Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Interpersonal psychotherapy. Current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

The quality of care for depressive and anxiety disorders in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Treatment of Depression Following Myocardial Infarction with Interpersonal Psychotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

Cognitive Therapy for Bipolar Illness—A Pilot Study of Relapse Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1529-1006.00008

21 January 2018

Identifiers

DOI

10.1111/1529-1006.00008

1 reference

19 April 2018

PubMed ID

26151569

1 reference

19 April 2018